SCHEMBL24434902

SCHEMBL24434902

CC(C)Cc1ccncc1CCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42
ABCB1 P08183 1/20 0.41
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
LMNA P02545 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CYP2D6 P10635 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
HIF1A Q16665 1/20 0.37
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24434614 0.81 HTR1A (0.45) HTR1ADRD2ABCB1ALDH1A1NPC1
SCHEMBL6547312 0.81 GABRA1 (0.47) HTR1ADRD2ABCB1SLC6A2SLC6A4
SCHEMBL18858537 0.80 AOC1 (0.43) CYP2D6CYP2C19
SCHEMBL9589198 0.79 LMNA (0.40) HTR1ADRD2ABCB1SLC6A2SLC6A4
SCHEMBL9587851 0.77 SIGMAR1 (0.37) LMNAKMT2ACYP2D6CYP2C9CYP2C19
SCHEMBL6385911 0.76 CYP11B1 (0.51) HTR1ADRD2ABCB1MEN1KMT2A
SCHEMBL9587199 0.76 LMNA (0.43) HTR1ADRD2LMNAMEN1KMT2A
SCHEMBL8270457 0.75 CYP2E1 (0.41) LMNACYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL24435135 0.74 ABCB1 (0.48) HTR1ADRD2ABCB1LMNAALDH1A1
SCHEMBL24435136 0.74 KDM4C (0.54) LMNAMEN1KMT2AALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153732-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153732-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G HTR1A 3598/4885DRD2 4602/4885ABCB1 905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.